Assessment of Anti-tumor Efficacy of Osimertinib in Non–Small Cell Lung Cancer Patients by Liquid Biopsy Using Bronchoalveolar Lavage Fluid, Plasma, or Pleural Effusion

PURPOSE: This study was to evaluate anti-tumor efficacy of osimertinib in patients positive for acquired epidermal growth factor receptor (EGFR) T790M mutation in liquid biopsy using plasma, bronchoalveolar lavage fluid (BALF) or bronchial washing fluid (BWF), and pleural effusion. MATERIALS AND MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yeon Joo, Ji, Won Jun, Lee, Jae-Cheol, Chun, Sung-Min, Choi, Chang-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582461/
https://www.ncbi.nlm.nih.gov/pubmed/35038824
http://dx.doi.org/10.4143/crt.2021.857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582461/
https://www.ncbi.nlm.nih.gov/pubmed/35038824
http://dx.doi.org/10.4143/crt.2021.857

Ejemplares similares